SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-597.84%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | +100.0% |
| 2024 | -2192.54% | -28.7% |
| 2023 | -1703.13% | -2592.2% |
| 2022 | -63.26% | -153.4% |
| 2021 | -24.96% | -165.2% |
| 2020 | 38.26% | +116.0% |
| 2019 | -239.22% | - |